Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RHC Holding Private Limited was a prominent Indian holding company and the primary investment vehicle for billionaires Malvinder and Shivinder Singh. The company held controlling stakes in major healthcare and pharmaceutical entities, most notably Fortis Healthcare, one of India's largest hospital chains, and Religare Enterprises, a financial services giant. Historically, the firm was also the parent company of Ranbaxy Laboratories, which was once India's largest generic pharmaceutical manufacturer before its sale to Daiichi Sankyo in 2008. In recent years, RHC Holding became the center of significant legal and financial controversies, including a multi-billion dollar arbitration dispute with Daiichi Sankyo and allegations of fund diversion. The company eventually faced insolvency proceedings and was ordered to be liquidated by Indian courts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RHC Holdings.